Transdermal delivery systems (TDS) provide therapy for periods between one and seven days. The increase in the interval between applications favours patient compliance and, in certain cases, optimizes caregivers work.

Another advantage of transdermal administration of drugs is the possibility of reaching sustained and controllable plasma levels of the drug, avoiding the characteristic peaks and valleys of the oral or injectable routes of administration, thus decreasing the risk of potential side effects or lack of activity.

We have also developed an “enhancer” technology applied on semi-solid dosage forms. The drug permeation using this technology allows us to reach therapeutic levels of drugs in the bloodstream.